In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteria

被引：17

作者：

Wexler, HM

Molitoris, D

Finegold, SM

机构：

[1] VAGLAHS, Microbial Dis Res Lab, Med Serv, Los Angeles, CA 90073 USA

[2] VAGLAHS, Res Serv, Los Angeles, CA 90073 USA

[3] Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90024 USA

[4] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 08期

关键词：

D O I：

10.1128/AAC.44.8.2222-2224.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The activity of MK-826 was compared to the activities of cefoxitin, ceftriaxone, imipenem, and meropenem against 363 gram-negative and gram-positive anaerobes by using NCCLS procedures. At least 98% of the strains were susceptible to the carbapenems. All strains of Clostridium perfringens, Fusobacterium nucleatum, Peptostreptococcus, and Sutterella wadsworthensis were susceptible to all agents tested.

引用

收藏

页码：2222 / 2224

页数：3

相关论文

共 12 条

[1] SUSCEPTIBILITY PATTERNS AND RESISTANCE TO IMIPENEM IN THE BACTEROIDES-FRAGILIS GROUP SPECIES IN JAPAN - A 4-YEAR STUDY [J].

BANDOH, K ;

UENO, K ;

WATANABE, K ;

KATO, N .

CLINICAL INFECTIOUS DISEASES, 1993, 16 :S382-S386

[2] THE BACTERIOLOGY OF GANGRENOUS AND PERFORATED APPENDICITIS - REVISITED [J].

BENNION, RS ;

BARON, EJ ;

THOMPSON, JE ;

DOWNES, J ;

SUMMANEN, P ;

TALAN, DA ;

FINEGOLD, SM .

ANNALS OF SURGERY, 1990, 211 (02) :165-171

[3] Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis [J].

Edwards, R ;

Greenwood, D .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :941-951

[4] In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests [J].

Fuchs, PC ;

Barry, AL ;

Brown, SD .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) :703-706

[5] In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345) [J].

Gill, CJ ;

Jackson, JJ ;

Gerckens, LS ;

Pelak, BA ;

Thompson, RK ;

Sundelof, JG ;

Kropp, H ;

Rosen, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1996-2001

[6] Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens [J].

Jacoby, G ;

Han, P ;

Tran, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1830-1831

[7] In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum β-lactamase- and extended-spectrum p-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates [J].

Kohler, J ;

Dorso, KL ;

Young, K ;

Hammond, GG ;

Rosen, H ;

Kropp, H ;

Silver, LL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1170-1176

[8]

National Committee for Clinical Laboratory Standard, 1997, M11A4 NCCLS

[9] Interactions between exogenous and endogenous retroviruses [J].

Rasmussen, HB .

JOURNAL OF BIOMEDICAL SCIENCE, 1997, 4 (01) :1-8

[10]

Summanen P, 1993, WADSWORTH ANAEROBIC